Yang ZY - Search Results

1

Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor.

Pegu A, Yang ZY, Boyington JC, Wu L, Ko SY, Schmidt SD, McKee K, Kong WP, Shi W, Chen X, Todd JP, Letvin NL, Huang J, Nason MC, Hoxie JA, Kwong PD, Connors M, Rao SS, Mascola JR, Nabel GJ. Pegu A, et al. Among authors: yang zy. Sci Transl Med. 2014 Jul 2;6(243):243ra88. doi: 10.1126/scitranslmed.3008992. Sci Transl Med. 2014. PMID: 24990883 Free PMC article.

2

Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.

Liu J, Woffendin C, Yang ZY, Nabel GJ. Liu J, et al. Among authors: yang zy. Gene Ther. 1994 Jan;1(1):32-7. Gene Ther. 1994. PMID: 7584057

3

Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells.

Woffendin C, Yang ZY, Udaykumar, Xu L, Yang NS, Sheehy MJ, Nabel GJ. Woffendin C, et al. Among authors: yang ns, yang zy. Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11581-5. doi: 10.1073/pnas.91.24.11581. Proc Natl Acad Sci U S A. 1994. PMID: 7972106 Free PMC article.

4

Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.

Woffendin C, Ranga U, Yang Z, Xu L, Nabel GJ. Woffendin C, et al. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2889-94. doi: 10.1073/pnas.93.7.2889. Proc Natl Acad Sci U S A. 1996. PMID: 8610137 Free PMC article.

5

Cell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory gene.

Ranga U, Woffendin C, Yang ZY, Xu L, Verma S, Littman DR, Nabel GJ. Ranga U, et al. Among authors: yang zy. J Virol. 1997 Sep;71(9):7020-9. doi: 10.1128/JVI.71.9.7020-7029.1997. J Virol. 1997. PMID: 9261432 Free PMC article.

6

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus.

Sanchez A, Yang ZY, Xu L, Nabel GJ, Crews T, Peters CJ. Sanchez A, et al. Among authors: yang zy. J Virol. 1998 Aug;72(8):6442-7. doi: 10.1128/JVI.72.8.6442-6447.1998. J Virol. 1998. PMID: 9658086 Free PMC article.

7

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.

Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ. Yang ZY, et al. Nat Med. 2000 Aug;6(8):886-9. doi: 10.1038/78645. Nat Med. 2000. PMID: 10932225

8

Development of a preventive vaccine for Ebola virus infection in primates.

Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ. Sullivan NJ, et al. Among authors: yang zy. Nature. 2000 Nov 30;408(6812):605-9. doi: 10.1038/35046108. Nature. 2000. PMID: 11117750

9

SM22alpha promoter targets gene expression to vascular smooth muscle cells in vitro and in vivo.

Akyürek LM, Yang ZY, Aoki K, San H, Nabel GJ, Parmacek MS, Nabel EG. Akyürek LM, et al. Among authors: yang zy. Mol Med. 2000 Nov;6(11):983-91. Mol Med. 2000. PMID: 11147575 Free PMC article.

10

Coexpression of guanylate kinase with thymidine kinase enhances prodrug cell killing in vitro and suppresses vascular smooth muscle cell proliferation in vivo.

Akyürek LM, Nallamshetty S, Aoki K, San H, Yang ZY, Nabel GJ, Nabel EG. Akyürek LM, et al. Among authors: yang zy. Mol Ther. 2001 May;3(5 Pt 1):779-86. doi: 10.1006/mthe.2001.0315. Mol Ther. 2001. PMID: 11356082 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,306 results

Search Page